Literature DB >> 14934758

The clinical use of triethylene melamine.

S C KRAVITZ, H D DIAMOND, L F CRAVER.   

Abstract

Entities:  

Keywords:  HODGKIN'S DISEASE/therapy; LEUKEMIA, LYMPHATIC/therapy; LEUKEMIA, MYELOCYTIC/therapy; TRIETHYLENE MELAMINE/therapeutic use

Mesh:

Substances:

Year:  1952        PMID: 14934758

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Chemotherapy of cancer.

Authors:  K A NEWTON
Journal:  Postgrad Med J       Date:  1958-12       Impact factor: 2.401

2.  The chemotherapy of malignant disease.

Authors:  R B SCOTT
Journal:  Br Med J       Date:  1958-01-04

3.  [Fatal uremia after triethylenemelamine treatment in chronic lymphatic leukemia].

Authors:  H MARTIN
Journal:  Klin Wochenschr       Date:  1953-03-15

4.  Chemotherapy in Malignant Disease: The Present Position.

Authors:  A E Buckle
Journal:  Postgrad Med J       Date:  1961-06       Impact factor: 2.401

5.  Current trends in cancer chemotherapy.

Authors:  B E HALL; F M WILLETT; T V FEICHTMEIR; E B REED; W F DOWLING
Journal:  Calif Med       Date:  1956-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.